Pfizer And Mylan Agree Japanese Transfer
As The Two Firms Extend Meridian EpiPen Supply Deal
Mylan and Pfizer have reached a transfer agreement for certain Pfizer assets covered under the firms’ collaboration for generic drugs in Japan, while further details have emerged of the EpiPen supply agreement conducted through Pfizer’s Meridian unit.
